Enlightify Inc

Finanzen von Enlightify Inc (CGA)

$1.980

0.000 (0.00%)Zum Schluss

Umsatzquellen von CGA

China Green Agriculture Inc (CGA) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Gufeng (fertilizer production), accounting for 48.5% of total sales, equivalent to $11.02M. Other significant revenue streams include Jinong (fertilizer production) and Yuxing. Understanding this composition is critical for investors evaluating how CGA navigates market cycles within the Agricultural Chemicals industry.

Profitabilität und Margen von CGA

Evaluating the bottom line, China Green Agriculture Inc maintains a gross margin of 22.96%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -10.16%, while the net margin is -10.61%. These profitability ratios, combined with a Return on Equity (ROE) of -25.22%, provide a clear picture of how effectively CGA converts its operational activities into shareholder value.

CGA im Vergleich zur Peergroup

In the context of the broader market, CGA competes directly with industry leaders such as LITM and RKDA. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, CGA's gross margin of 22.96% stands against LITM's N/A and RKDA's 36.36%. Such benchmarking helps identify whether China Green Agriculture Inc is trading at a premium or discount relative to its financial performance.

Financials

FY2025Q1
YoY:
-22.47%
17.36M
Total Revenue
FY2025Q1
YoY:
-1.18%
-1.76M
Operating Profit
FY2025Q1
YoY:
+3.25%
-1.84M
Net Income after Tax
FY2025Q1
YoY:
-7.69%
-0.12
EPS - Diluted
FY2025Q1
YoY:
+21.96%
-2.60M
Free Cash Flow
FY2025Q1
YoY:
+10.60%
22.96
Gross Profit Margin - %
FY2025Q1
YoY:
+1135.51%
-13.22
FCF Margin - %
FY2025Q1
YoY:
+33.12%
-10.61
Net Margin - %

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten